Salomon Azoulay, Chief Medical Officer at MBX Biosciences, Inc. (MBX), sold 70,003 shares at $38.38 ($2.7M) on 2026-05-08, disclosed to the SEC on 2026-05-11.
Scheduled sale ($2.7M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.30 | 15,003 | $575K | 21.4% |
| 2 | $38.38 | 55,000 | $2.1M | 78.6% |
| Total | $38.36 avg | 70,003 | $2.7M | 100% |
| Filing → |